Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia
· Delayed Price · Currency is AUD 0.295
0.00 (0.00%)
At close: Mar 6, 2026
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 234.00 million as of March 6, 2026. Its market cap has increased by 977.98% in one year.
Market Cap
234.00M
Enterprise Value
239.21M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has increased from 196.70M to 234.00M, an increase of 18.96%. That is a compound annual growth rate of 3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 235.32M | 4.89% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 215.92M |
| EMVision Medical Devices | 159.85M |
| SomnoMed | 146.36M |
| PolyNovo | 607.94M |
| Cleo Diagnostics | 73.22M |
| Compumedics | 60.93M |
| Anteris Technologies Global | 865.37M |
| Micro-X | 48.50M |